Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases

E-ISSN： 1097-0142|121|23|4231-4239

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.23, 2015-12, pp. : 4231-4239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of stroke treatments and secondary preventions

By Pan Feng Hernandez Luis Ward Alex

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1751-1760

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of different postoperative analgesic treatments

By Engoren Milo

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1507-1519

Informa Healthcare

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite

Subgroups and Heterogeneity in Cost-Effectiveness Analysis

By Sculpher Mark

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 799-806

Adis International

Access to resources Recommend Favorite